HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Chemical and immunochemical characterisation of substance P-like immunoreactivity and physalaemin-like immunoreactivity in a carcinoid tumour.

Abstract
Extracts of a carcinoid tumour, resected from the mid-portion of the ileum of a patient with no symptoms of endocrine disorder, were associated with a high concentration of substance P-like immunoreactivity. Using reverse-phase high performance liquid chromatography and antisera specifically directed against the C-terminal and N-terminal regions of substance P and against the N-terminal region of physalaemin, the following components were isolated and identified: substance P and its oxidised form, [pGlu5]substance P-(5-11) peptide and its oxidised form, and the oxidised form of physalaemin. The identity of tumour substance P with the undecapeptide was confirmed by amino acid analysis and high performance ion-exchange chromatography. In vitro incubation of tumour tissue from a lymph node metastasis from the same patient with [3H]leucine resulted in incorporation of radioactivity into newly synthesised substance P.
AuthorsJ M Conlon, G Schäfer, W E Schmidt, L H Lazarus, H D Becker, W Creutzfeldt
JournalRegulatory peptides (Regul Pept) Vol. 11 Issue 2 Pg. 117-32 (Jun 1985) ISSN: 0167-0115 [Print] Netherlands
PMID2412263 (Publication Type: Case Reports, Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Kinins
  • Physalaemin
  • Substance P
Topics
  • Carcinoid Tumor (analysis, blood, pathology)
  • Chromatography, High Pressure Liquid
  • Cross Reactions
  • Humans
  • Ileal Neoplasms (analysis, blood, pathology)
  • Kinins (analysis)
  • Male
  • Middle Aged
  • Physalaemin (analysis)
  • Substance P (analysis, biosynthesis, blood)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: